A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Proteomics ...
Peter Searson is leading a Johns Hopkins University team that is unravelling how Alzheimer's and other diseases disrupt the blood-brain barrier, the complex interface that allows or blocks the passage ...
Triple-negative breast cancer—the most aggressive breast cancer subtype—has a high propensity for brain metastases, with limited treatments and poor prognosis. The blood–brain barrier, long viewed as ...
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results